0
U.S. (TOLL FREE)
+1 (315) 215-3225
Automative

0
U.S. (TOLL FREE)
+1 (315) 215-3225
Global Adult Chronic Hepatitis B Treatment Market Research Report 2023
Published Date: January 2023
|
Report Code: QYRE-Auto-15A13061
Home | Market Reports | Health| Health Conditions| Infectious Diseases
Global Adult Chronic Hepatitis B Treatment Market Research Report 2023
BUY CHAPTERS

Global Adult Chronic Hepatitis B Treatment Market Research Report 2023

Code: QYRE-Auto-15A13061
Report
January 2023
Pages:91
QYResearch
Buy Now with 15% Discount
DESCRIPTION
TABLE OF CONTENT
TABLES & FIGURES

Global Adult Chronic Hepatitis B Treatment Market

The global Adult Chronic Hepatitis B Treatment market was valued at US$ million in 2022 and is anticipated to reach US$ million by 2029, witnessing a CAGR of % during the forecast period 2023-2029. The influence of COVID-19 and the Russia-Ukraine War were considered while estimating market sizes.
North American market for Adult Chronic Hepatitis B Treatment is estimated to increase from $ million in 2023 to reach $ million by 2029, at a CAGR of % during the forecast period of 2023 through 2029.
Asia-Pacific market for Adult Chronic Hepatitis B Treatment is estimated to increase from $ million in 2023 to reach $ million by 2029, at a CAGR of % during the forecast period of 2023 through 2029.
The global market for Adult Chronic Hepatitis B Treatment in Hospitals is estimated to increase from $ million in 2023 to $ million by 2029, at a CAGR of % during the forecast period of 2023 through 2029.
The key global companies of Adult Chronic Hepatitis B Treatment include Novartis, ViiV Healthcare, Bristol-Myers Squibb, Gilead Sciences, Accord Healthcare, Teva Pharmaceuticals, Apotex Corp, CTTQ and Arbutus Biopharma, etc. In 2022, the world's top three vendors accounted for approximately % of the revenue.

Report Scope

This report aims to provide a comprehensive presentation of the global market for Adult Chronic Hepatitis B Treatment, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Adult Chronic Hepatitis B Treatment.
The Adult Chronic Hepatitis B Treatment market size, estimations, and forecasts are provided in terms of and revenue ($ millions), considering 2022 as the base year, with history and forecast data for the period from 2018 to 2029. This report segments the global Adult Chronic Hepatitis B Treatment market comprehensively. Regional market sizes, concerning products by type, by application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Adult Chronic Hepatitis B Treatment companies, new entrants, and industry chain related companies in this market with information on the revenues for the overall market and the sub-segments across the different segments, by company, by type, by application, and by regions.

Key Segmentations

By Company

  • Novartis
  • ViiV Healthcare
  • Bristol-Myers Squibb
  • Gilead Sciences
  • Accord Healthcare
  • Teva Pharmaceuticals
  • Apotex Corp
  • CTTQ
  • Arbutus Biopharma
  • Lupin Pharmaceuticals

Segment by Type

  • Interferon
  • Antiviral Drugs

Segment by Application

  • Hospitals
  • Homecare
  • Clinics
  • Others

By Region

  • North America
  • United States
  • Canada
  • Europe
  • Germany
  • France
  • UK
  • Italy
  • Russia
  • Nordic Countries
  • Rest of Europe
  • Asia-Pacific
  • China
  • Japan
  • South Korea
  • Southeast Asia
  • India
  • Australia
  • Rest of Asia
  • Latin America
  • Mexico
  • Brazil
  • Rest of Latin America
  • Middle East & Africa
  • Turkey
  • Saudi Arabia
  • UAE
  • Rest of MEA

Core Chapters

  • Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
  • Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
  • Chapter 3: Detailed analysis of Adult Chronic Hepatitis B Treatment companies’ competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
  • Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
  • Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
  • Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
  • Chapter 11: Provides profiles of key players, introducing the basic situation of the key companies in the market in detail, including product revenue, gross margin, product introduction, recent development, etc.
  • Chapter 12: The main points and conclusions of the report.

Scope of Global Adult Chronic Hepatitis B Treatment Market Report

Report MetricDetails
Report NameGlobal Adult Chronic Hepatitis B Treatment Market
Base Year2022
Forecasted years2023-2029
Forecast unitsUSD
Report coverageRevenue and volume forecast, company share, competitive landscape, growth factors and trends
Geographic regions coveredNorth America, Europe, Asia Pacific, Latin America, Middle East & Africa
1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Adult Chronic Hepatitis B Treatment Market Size Growth Rate by Type: 2018 VS 2022 VS 2029
1.2.2 Interferon
1.2.3 Antiviral Drugs
1.3 Market by Application
1.3.1 Global Adult Chronic Hepatitis B Treatment Market Growth by Application: 2018 VS 2022 VS 2029
1.3.2 Hospitals
1.3.3 Homecare
1.3.4 Clinics
1.3.5 Others
1.4 Study Objectives
1.5 Years Considered
1.6 Years Considered
2 Global Growth Trends
2.1 Global Adult Chronic Hepatitis B Treatment Market Perspective (2018-2029)
2.2 Adult Chronic Hepatitis B Treatment Growth Trends by Region
2.2.1 Global Adult Chronic Hepatitis B Treatment Market Size by Region: 2018 VS 2022 VS 2029
2.2.2 Adult Chronic Hepatitis B Treatment Historic Market Size by Region (2018-2023)
2.2.3 Adult Chronic Hepatitis B Treatment Forecasted Market Size by Region (2024-2029)
2.3 Adult Chronic Hepatitis B Treatment Market Dynamics
2.3.1 Adult Chronic Hepatitis B Treatment Industry Trends
2.3.2 Adult Chronic Hepatitis B Treatment Market Drivers
2.3.3 Adult Chronic Hepatitis B Treatment Market Challenges
2.3.4 Adult Chronic Hepatitis B Treatment Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Adult Chronic Hepatitis B Treatment Players by Revenue
3.1.1 Global Top Adult Chronic Hepatitis B Treatment Players by Revenue (2018-2023)
3.1.2 Global Adult Chronic Hepatitis B Treatment Revenue Market Share by Players (2018-2023)
3.2 Global Adult Chronic Hepatitis B Treatment Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Players Covered: Ranking by Adult Chronic Hepatitis B Treatment Revenue
3.4 Global Adult Chronic Hepatitis B Treatment Market Concentration Ratio
3.4.1 Global Adult Chronic Hepatitis B Treatment Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Adult Chronic Hepatitis B Treatment Revenue in 2022
3.5 Adult Chronic Hepatitis B Treatment Key Players Head office and Area Served
3.6 Key Players Adult Chronic Hepatitis B Treatment Product Solution and Service
3.7 Date of Enter into Adult Chronic Hepatitis B Treatment Market
3.8 Mergers & Acquisitions, Expansion Plans
4 Adult Chronic Hepatitis B Treatment Breakdown Data by Type
4.1 Global Adult Chronic Hepatitis B Treatment Historic Market Size by Type (2018-2023)
4.2 Global Adult Chronic Hepatitis B Treatment Forecasted Market Size by Type (2024-2029)
5 Adult Chronic Hepatitis B Treatment Breakdown Data by Application
5.1 Global Adult Chronic Hepatitis B Treatment Historic Market Size by Application (2018-2023)
5.2 Global Adult Chronic Hepatitis B Treatment Forecasted Market Size by Application (2024-2029)
6 North America
6.1 North America Adult Chronic Hepatitis B Treatment Market Size (2018-2029)
6.2 North America Adult Chronic Hepatitis B Treatment Market Growth Rate by Country: 2018 VS 2022 VS 2029
6.3 North America Adult Chronic Hepatitis B Treatment Market Size by Country (2018-2023)
6.4 North America Adult Chronic Hepatitis B Treatment Market Size by Country (2024-2029)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe Adult Chronic Hepatitis B Treatment Market Size (2018-2029)
7.2 Europe Adult Chronic Hepatitis B Treatment Market Growth Rate by Country: 2018 VS 2022 VS 2029
7.3 Europe Adult Chronic Hepatitis B Treatment Market Size by Country (2018-2023)
7.4 Europe Adult Chronic Hepatitis B Treatment Market Size by Country (2024-2029)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific Adult Chronic Hepatitis B Treatment Market Size (2018-2029)
8.2 Asia-Pacific Adult Chronic Hepatitis B Treatment Market Growth Rate by Region: 2018 VS 2022 VS 2029
8.3 Asia-Pacific Adult Chronic Hepatitis B Treatment Market Size by Region (2018-2023)
8.4 Asia-Pacific Adult Chronic Hepatitis B Treatment Market Size by Region (2024-2029)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia
9 Latin America
9.1 Latin America Adult Chronic Hepatitis B Treatment Market Size (2018-2029)
9.2 Latin America Adult Chronic Hepatitis B Treatment Market Growth Rate by Country: 2018 VS 2022 VS 2029
9.3 Latin America Adult Chronic Hepatitis B Treatment Market Size by Country (2018-2023)
9.4 Latin America Adult Chronic Hepatitis B Treatment Market Size by Country (2024-2029)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Adult Chronic Hepatitis B Treatment Market Size (2018-2029)
10.2 Middle East & Africa Adult Chronic Hepatitis B Treatment Market Growth Rate by Country: 2018 VS 2022 VS 2029
10.3 Middle East & Africa Adult Chronic Hepatitis B Treatment Market Size by Country (2018-2023)
10.4 Middle East & Africa Adult Chronic Hepatitis B Treatment Market Size by Country (2024-2029)
10.5 Turkey
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 Novartis
11.1.1 Novartis Company Detail
11.1.2 Novartis Business Overview
11.1.3 Novartis Adult Chronic Hepatitis B Treatment Introduction
11.1.4 Novartis Revenue in Adult Chronic Hepatitis B Treatment Business (2018-2023)
11.1.5 Novartis Recent Development
11.2 ViiV Healthcare
11.2.1 ViiV Healthcare Company Detail
11.2.2 ViiV Healthcare Business Overview
11.2.3 ViiV Healthcare Adult Chronic Hepatitis B Treatment Introduction
11.2.4 ViiV Healthcare Revenue in Adult Chronic Hepatitis B Treatment Business (2018-2023)
11.2.5 ViiV Healthcare Recent Development
11.3 Bristol-Myers Squibb
11.3.1 Bristol-Myers Squibb Company Detail
11.3.2 Bristol-Myers Squibb Business Overview
11.3.3 Bristol-Myers Squibb Adult Chronic Hepatitis B Treatment Introduction
11.3.4 Bristol-Myers Squibb Revenue in Adult Chronic Hepatitis B Treatment Business (2018-2023)
11.3.5 Bristol-Myers Squibb Recent Development
11.4 Gilead Sciences
11.4.1 Gilead Sciences Company Detail
11.4.2 Gilead Sciences Business Overview
11.4.3 Gilead Sciences Adult Chronic Hepatitis B Treatment Introduction
11.4.4 Gilead Sciences Revenue in Adult Chronic Hepatitis B Treatment Business (2018-2023)
11.4.5 Gilead Sciences Recent Development
11.5 Accord Healthcare
11.5.1 Accord Healthcare Company Detail
11.5.2 Accord Healthcare Business Overview
11.5.3 Accord Healthcare Adult Chronic Hepatitis B Treatment Introduction
11.5.4 Accord Healthcare Revenue in Adult Chronic Hepatitis B Treatment Business (2018-2023)
11.5.5 Accord Healthcare Recent Development
11.6 Teva Pharmaceuticals
11.6.1 Teva Pharmaceuticals Company Detail
11.6.2 Teva Pharmaceuticals Business Overview
11.6.3 Teva Pharmaceuticals Adult Chronic Hepatitis B Treatment Introduction
11.6.4 Teva Pharmaceuticals Revenue in Adult Chronic Hepatitis B Treatment Business (2018-2023)
11.6.5 Teva Pharmaceuticals Recent Development
11.7 Apotex Corp
11.7.1 Apotex Corp Company Detail
11.7.2 Apotex Corp Business Overview
11.7.3 Apotex Corp Adult Chronic Hepatitis B Treatment Introduction
11.7.4 Apotex Corp Revenue in Adult Chronic Hepatitis B Treatment Business (2018-2023)
11.7.5 Apotex Corp Recent Development
11.8 CTTQ
11.8.1 CTTQ Company Detail
11.8.2 CTTQ Business Overview
11.8.3 CTTQ Adult Chronic Hepatitis B Treatment Introduction
11.8.4 CTTQ Revenue in Adult Chronic Hepatitis B Treatment Business (2018-2023)
11.8.5 CTTQ Recent Development
11.9 Arbutus Biopharma
11.9.1 Arbutus Biopharma Company Detail
11.9.2 Arbutus Biopharma Business Overview
11.9.3 Arbutus Biopharma Adult Chronic Hepatitis B Treatment Introduction
11.9.4 Arbutus Biopharma Revenue in Adult Chronic Hepatitis B Treatment Business (2018-2023)
11.9.5 Arbutus Biopharma Recent Development
11.10 Lupin Pharmaceuticals
11.10.1 Lupin Pharmaceuticals Company Detail
11.10.2 Lupin Pharmaceuticals Business Overview
11.10.3 Lupin Pharmaceuticals Adult Chronic Hepatitis B Treatment Introduction
11.10.4 Lupin Pharmaceuticals Revenue in Adult Chronic Hepatitis B Treatment Business (2018-2023)
11.10.5 Lupin Pharmaceuticals Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details
List of Tables
    Table 1. Global Adult Chronic Hepatitis B Treatment Market Size Growth Rate by Type (US$ Million): 2018 VS 2022 VS 2029
    Table 2. Key Players of Interferon
    Table 3. Key Players of Antiviral Drugs
    Table 4. Global Adult Chronic Hepatitis B Treatment Market Size Growth by Application (US$ Million): 2018 VS 2022 VS 2029
    Table 5. Global Adult Chronic Hepatitis B Treatment Market Size by Region (US$ Million): 2018 VS 2022 VS 2029
    Table 6. Global Adult Chronic Hepatitis B Treatment Market Size by Region (2018-2023) & (US$ Million)
    Table 7. Global Adult Chronic Hepatitis B Treatment Market Share by Region (2018-2023)
    Table 8. Global Adult Chronic Hepatitis B Treatment Forecasted Market Size by Region (2024-2029) & (US$ Million)
    Table 9. Global Adult Chronic Hepatitis B Treatment Market Share by Region (2024-2029)
    Table 10. Adult Chronic Hepatitis B Treatment Market Trends
    Table 11. Adult Chronic Hepatitis B Treatment Market Drivers
    Table 12. Adult Chronic Hepatitis B Treatment Market Challenges
    Table 13. Adult Chronic Hepatitis B Treatment Market Restraints
    Table 14. Global Adult Chronic Hepatitis B Treatment Revenue by Players (2018-2023) & (US$ Million)
    Table 15. Global Adult Chronic Hepatitis B Treatment Market Share by Players (2018-2023)
    Table 16. Global Top Adult Chronic Hepatitis B Treatment Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Adult Chronic Hepatitis B Treatment as of 2022)
    Table 17. Ranking of Global Top Adult Chronic Hepatitis B Treatment Companies by Revenue (US$ Million) in 2022
    Table 18. Global 5 Largest Players Market Share by Adult Chronic Hepatitis B Treatment Revenue (CR5 and HHI) & (2018-2023)
    Table 19. Key Players Headquarters and Area Served
    Table 20. Key Players Adult Chronic Hepatitis B Treatment Product Solution and Service
    Table 21. Date of Enter into Adult Chronic Hepatitis B Treatment Market
    Table 22. Mergers & Acquisitions, Expansion Plans
    Table 23. Global Adult Chronic Hepatitis B Treatment Market Size by Type (2018-2023) & (US$ Million)
    Table 24. Global Adult Chronic Hepatitis B Treatment Revenue Market Share by Type (2018-2023)
    Table 25. Global Adult Chronic Hepatitis B Treatment Forecasted Market Size by Type (2024-2029) & (US$ Million)
    Table 26. Global Adult Chronic Hepatitis B Treatment Revenue Market Share by Type (2024-2029)
    Table 27. Global Adult Chronic Hepatitis B Treatment Market Size by Application (2018-2023) & (US$ Million)
    Table 28. Global Adult Chronic Hepatitis B Treatment Revenue Market Share by Application (2018-2023)
    Table 29. Global Adult Chronic Hepatitis B Treatment Forecasted Market Size by Application (2024-2029) & (US$ Million)
    Table 30. Global Adult Chronic Hepatitis B Treatment Revenue Market Share by Application (2024-2029)
    Table 31. North America Adult Chronic Hepatitis B Treatment Market Size Growth Rate by Country (US$ Million): 2018 VS 2022 VS 2029
    Table 32. North America Adult Chronic Hepatitis B Treatment Market Size by Country (2018-2023) & (US$ Million)
    Table 33. North America Adult Chronic Hepatitis B Treatment Market Size by Country (2024-2029) & (US$ Million)
    Table 34. Europe Adult Chronic Hepatitis B Treatment Market Size Growth Rate by Country (US$ Million): 2018 VS 2022 VS 2029
    Table 35. Europe Adult Chronic Hepatitis B Treatment Market Size by Country (2018-2023) & (US$ Million)
    Table 36. Europe Adult Chronic Hepatitis B Treatment Market Size by Country (2024-2029) & (US$ Million)
    Table 37. Asia-Pacific Adult Chronic Hepatitis B Treatment Market Size Growth Rate by Region (US$ Million): 2018 VS 2022 VS 2029
    Table 38. Asia-Pacific Adult Chronic Hepatitis B Treatment Market Size by Region (2018-2023) & (US$ Million)
    Table 39. Asia-Pacific Adult Chronic Hepatitis B Treatment Market Size by Region (2024-2029) & (US$ Million)
    Table 40. Latin America Adult Chronic Hepatitis B Treatment Market Size Growth Rate by Country (US$ Million): 2018 VS 2022 VS 2029
    Table 41. Latin America Adult Chronic Hepatitis B Treatment Market Size by Country (2018-2023) & (US$ Million)
    Table 42. Latin America Adult Chronic Hepatitis B Treatment Market Size by Country (2024-2029) & (US$ Million)
    Table 43. Middle East & Africa Adult Chronic Hepatitis B Treatment Market Size Growth Rate by Country (US$ Million): 2018 VS 2022 VS 2029
    Table 44. Middle East & Africa Adult Chronic Hepatitis B Treatment Market Size by Country (2018-2023) & (US$ Million)
    Table 45. Middle East & Africa Adult Chronic Hepatitis B Treatment Market Size by Country (2024-2029) & (US$ Million)
    Table 46. Novartis Company Detail
    Table 47. Novartis Business Overview
    Table 48. Novartis Adult Chronic Hepatitis B Treatment Product
    Table 49. Novartis Revenue in Adult Chronic Hepatitis B Treatment Business (2018-2023) & (US$ Million)
    Table 50. Novartis Recent Development
    Table 51. ViiV Healthcare Company Detail
    Table 52. ViiV Healthcare Business Overview
    Table 53. ViiV Healthcare Adult Chronic Hepatitis B Treatment Product
    Table 54. ViiV Healthcare Revenue in Adult Chronic Hepatitis B Treatment Business (2018-2023) & (US$ Million)
    Table 55. ViiV Healthcare Recent Development
    Table 56. Bristol-Myers Squibb Company Detail
    Table 57. Bristol-Myers Squibb Business Overview
    Table 58. Bristol-Myers Squibb Adult Chronic Hepatitis B Treatment Product
    Table 59. Bristol-Myers Squibb Revenue in Adult Chronic Hepatitis B Treatment Business (2018-2023) & (US$ Million)
    Table 60. Bristol-Myers Squibb Recent Development
    Table 61. Gilead Sciences Company Detail
    Table 62. Gilead Sciences Business Overview
    Table 63. Gilead Sciences Adult Chronic Hepatitis B Treatment Product
    Table 64. Gilead Sciences Revenue in Adult Chronic Hepatitis B Treatment Business (2018-2023) & (US$ Million)
    Table 65. Gilead Sciences Recent Development
    Table 66. Accord Healthcare Company Detail
    Table 67. Accord Healthcare Business Overview
    Table 68. Accord Healthcare Adult Chronic Hepatitis B Treatment Product
    Table 69. Accord Healthcare Revenue in Adult Chronic Hepatitis B Treatment Business (2018-2023) & (US$ Million)
    Table 70. Accord Healthcare Recent Development
    Table 71. Teva Pharmaceuticals Company Detail
    Table 72. Teva Pharmaceuticals Business Overview
    Table 73. Teva Pharmaceuticals Adult Chronic Hepatitis B Treatment Product
    Table 74. Teva Pharmaceuticals Revenue in Adult Chronic Hepatitis B Treatment Business (2018-2023) & (US$ Million)
    Table 75. Teva Pharmaceuticals Recent Development
    Table 76. Apotex Corp Company Detail
    Table 77. Apotex Corp Business Overview
    Table 78. Apotex Corp Adult Chronic Hepatitis B Treatment Product
    Table 79. Apotex Corp Revenue in Adult Chronic Hepatitis B Treatment Business (2018-2023) & (US$ Million)
    Table 80. Apotex Corp Recent Development
    Table 81. CTTQ Company Detail
    Table 82. CTTQ Business Overview
    Table 83. CTTQ Adult Chronic Hepatitis B Treatment Product
    Table 84. CTTQ Revenue in Adult Chronic Hepatitis B Treatment Business (2018-2023) & (US$ Million)
    Table 85. CTTQ Recent Development
    Table 86. Arbutus Biopharma Company Detail
    Table 87. Arbutus Biopharma Business Overview
    Table 88. Arbutus Biopharma Adult Chronic Hepatitis B Treatment Product
    Table 89. Arbutus Biopharma Revenue in Adult Chronic Hepatitis B Treatment Business (2018-2023) & (US$ Million)
    Table 90. Arbutus Biopharma Recent Development
    Table 91. Lupin Pharmaceuticals Company Detail
    Table 92. Lupin Pharmaceuticals Business Overview
    Table 93. Lupin Pharmaceuticals Adult Chronic Hepatitis B Treatment Product
    Table 94. Lupin Pharmaceuticals Revenue in Adult Chronic Hepatitis B Treatment Business (2018-2023) & (US$ Million)
    Table 95. Lupin Pharmaceuticals Recent Development
    Table 96. Research Programs/Design for This Report
    Table 97. Key Data Information from Secondary Sources
    Table 98. Key Data Information from Primary Sources
List of Figures
    Figure 1. Global Adult Chronic Hepatitis B Treatment Market Size Comparison by Type (2023-2029) & (US$ Million)
    Figure 2. Global Adult Chronic Hepatitis B Treatment Market Share by Type: 2022 VS 2029
    Figure 3. Interferon Features
    Figure 4. Antiviral Drugs Features
    Figure 5. Global Adult Chronic Hepatitis B Treatment Market Size Comparison by Application (2023-2029) & (US$ Million)
    Figure 6. Global Adult Chronic Hepatitis B Treatment Market Share by Application: 2022 VS 2029
    Figure 7. Hospitals Case Studies
    Figure 8. Homecare Case Studies
    Figure 9. Clinics Case Studies
    Figure 10. Others Case Studies
    Figure 11. Adult Chronic Hepatitis B Treatment Report Years Considered
    Figure 12. Global Adult Chronic Hepatitis B Treatment Market Size (US$ Million), Year-over-Year: 2018-2029
    Figure 13. Global Adult Chronic Hepatitis B Treatment Market Size, (US$ Million), 2018 VS 2022 VS 2029
    Figure 14. Global Adult Chronic Hepatitis B Treatment Market Share by Region: 2022 VS 2029
    Figure 15. Global Adult Chronic Hepatitis B Treatment Market Share by Players in 2022
    Figure 16. Global Top Adult Chronic Hepatitis B Treatment Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Adult Chronic Hepatitis B Treatment as of 2022)
    Figure 17. The Top 10 and 5 Players Market Share by Adult Chronic Hepatitis B Treatment Revenue in 2022
    Figure 18. North America Adult Chronic Hepatitis B Treatment Market Size YoY Growth (2018-2029) & (US$ Million)
    Figure 19. North America Adult Chronic Hepatitis B Treatment Market Share by Country (2018-2029)
    Figure 20. United States Adult Chronic Hepatitis B Treatment Market Size YoY Growth (2018-2029) & (US$ Million)
    Figure 21. Canada Adult Chronic Hepatitis B Treatment Market Size YoY Growth (2018-2029) & (US$ Million)
    Figure 22. Europe Adult Chronic Hepatitis B Treatment Market Size YoY Growth (2018-2029) & (US$ Million)
    Figure 23. Europe Adult Chronic Hepatitis B Treatment Market Share by Country (2018-2029)
    Figure 24. Germany Adult Chronic Hepatitis B Treatment Market Size YoY Growth (2018-2029) & (US$ Million)
    Figure 25. France Adult Chronic Hepatitis B Treatment Market Size YoY Growth (2018-2029) & (US$ Million)
    Figure 26. U.K. Adult Chronic Hepatitis B Treatment Market Size YoY Growth (2018-2029) & (US$ Million)
    Figure 27. Italy Adult Chronic Hepatitis B Treatment Market Size YoY Growth (2018-2029) & (US$ Million)
    Figure 28. Russia Adult Chronic Hepatitis B Treatment Market Size YoY Growth (2018-2029) & (US$ Million)
    Figure 29. Nordic Countries Adult Chronic Hepatitis B Treatment Market Size YoY Growth (2018-2029) & (US$ Million)
    Figure 30. Asia-Pacific Adult Chronic Hepatitis B Treatment Market Size YoY Growth (2018-2029) & (US$ Million)
    Figure 31. Asia-Pacific Adult Chronic Hepatitis B Treatment Market Share by Region (2018-2029)
    Figure 32. China Adult Chronic Hepatitis B Treatment Market Size YoY Growth (2018-2029) & (US$ Million)
    Figure 33. Japan Adult Chronic Hepatitis B Treatment Market Size YoY Growth (2018-2029) & (US$ Million)
    Figure 34. South Korea Adult Chronic Hepatitis B Treatment Market Size YoY Growth (2018-2029) & (US$ Million)
    Figure 35. Southeast Asia Adult Chronic Hepatitis B Treatment Market Size YoY Growth (2018-2029) & (US$ Million)
    Figure 36. India Adult Chronic Hepatitis B Treatment Market Size YoY Growth (2018-2029) & (US$ Million)
    Figure 37. Australia Adult Chronic Hepatitis B Treatment Market Size YoY Growth (2018-2029) & (US$ Million)
    Figure 38. Latin America Adult Chronic Hepatitis B Treatment Market Size YoY Growth (2018-2029) & (US$ Million)
    Figure 39. Latin America Adult Chronic Hepatitis B Treatment Market Share by Country (2018-2029)
    Figure 40. Mexico Adult Chronic Hepatitis B Treatment Market Size YoY Growth (2018-2029) & (US$ Million)
    Figure 41. Brazil Adult Chronic Hepatitis B Treatment Market Size YoY Growth (2018-2029) & (US$ Million)
    Figure 42. Middle East & Africa Adult Chronic Hepatitis B Treatment Market Size YoY Growth (2018-2029) & (US$ Million)
    Figure 43. Middle East & Africa Adult Chronic Hepatitis B Treatment Market Share by Country (2018-2029)
    Figure 44. Turkey Adult Chronic Hepatitis B Treatment Market Size YoY Growth (2018-2029) & (US$ Million)
    Figure 45. Saudi Arabia Adult Chronic Hepatitis B Treatment Market Size YoY Growth (2018-2029) & (US$ Million)
    Figure 46. Novartis Revenue Growth Rate in Adult Chronic Hepatitis B Treatment Business (2018-2023)
    Figure 47. ViiV Healthcare Revenue Growth Rate in Adult Chronic Hepatitis B Treatment Business (2018-2023)
    Figure 48. Bristol-Myers Squibb Revenue Growth Rate in Adult Chronic Hepatitis B Treatment Business (2018-2023)
    Figure 49. Gilead Sciences Revenue Growth Rate in Adult Chronic Hepatitis B Treatment Business (2018-2023)
    Figure 50. Accord Healthcare Revenue Growth Rate in Adult Chronic Hepatitis B Treatment Business (2018-2023)
    Figure 51. Teva Pharmaceuticals Revenue Growth Rate in Adult Chronic Hepatitis B Treatment Business (2018-2023)
    Figure 52. Apotex Corp Revenue Growth Rate in Adult Chronic Hepatitis B Treatment Business (2018-2023)
    Figure 53. CTTQ Revenue Growth Rate in Adult Chronic Hepatitis B Treatment Business (2018-2023)
    Figure 54. Arbutus Biopharma Revenue Growth Rate in Adult Chronic Hepatitis B Treatment Business (2018-2023)
    Figure 55. Lupin Pharmaceuticals Revenue Growth Rate in Adult Chronic Hepatitis B Treatment Business (2018-2023)
    Figure 56. Bottom-up and Top-down Approaches for This Report
    Figure 57. Data Triangulation
    Figure 58. Key Executives Interviewed
SELECT A FORMAT
Added to Cart
Electronic (PDF)

$2900

This license allows only one user to access the PDF.
Electronic (PDF)

$4350

This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together
Electronic (PDF)

$5800

This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report
Add to Cart
Buy Now (15% Discount)

OUR CUSTOMER

SIS Group of Schools

SIMILAR REPORTS

 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 

RELATED REPORTS

Global Vaccine Shipping Box Market Research Report 2024

120 Pages
Type: Report
Code: QYRE-Auto-20I7636
Thu Mar 28 00:00:00 UTC 2024

Add to Cart

Global Vaccine Refrigerant Market Research Report 2024

120 Pages
Type: Report
Code: QYRE-Auto-6Z7970
Thu Mar 28 00:00:00 UTC 2024

Add to Cart

Global Human Vaccine Market Research Report 2024

120 Pages
Type: Report
Code: QYRE-Auto-476
Fri Feb 23 00:00:00 UTC 2024

Add to Cart

Global Influenza Daignostic Market Research Report 2024

120 Pages
Type: Report
Code: QYRE-Auto-12A5908
Fri Feb 23 00:00:00 UTC 2024

Add to Cart